...and it's encouraging that Dr Player wants his remuneration to be primarily a milestone-linked share incentive package.
“I am excited by the circadian heart rate technology and the opportunity to validate and then commercialize it", he says.
"Should it be successfully validated it will represent a major breakthrough in the diagnosis of, and treatment outcomes for depression and other mental health disorders.”
BPO Price at posting:
0.3¢ Sentiment: Hold Disclosure: Held